A new study conducted by the World Health Organization (WHO) suggests that in addition to providing significant improvements in public health, investment in the diagnosis and prevention of ...

For the first time in the history of the National Tuberculosis Coalition of America, or NTCA, a representative from the ...

The Princeton Tuberculosis Awareness Group, an undergraduate student organization that aims to spread awareness about tuberculosis in the community, is holding an informational event today. From 11 ...

Despite efforts to eliminate the disease, 13 million Americans are living with latent tuberculosis infection, according to the most recent statistics from the National Health and Nutrition Examination ...

Every year on March 24, the world pauses to reflect on one of the oldest yet still pressing public health challenges, tuberculosis (TB). Despite medical advancements, TB continues to affect millions ...

Until COVID-19, tuberculosis was the world's deadliest infectious disease, killing about 1.5 million people annually. Contrary to public perception, the disease is still active in the United States.

FDA cleared generic rifapentine for active pulmonary TB (≥12 years) with susceptible isolates, requiring combination therapy with other active antitubercular agents. Authorization also covers LTBI (≥2 ...

Dolutegravir-based ART with isoniazid was safe and effective for tuberculosis prevention in ART-naïve HIV patients, leading to rapid viral suppression. The study reported minimal adverse events, with ...

The number of U.S. tuberculosis cases in 2023 was the highest in a decade, the Centers for Disease Control and Prevention has announced. The CDC said on its website Thursday that "overall, cases ...

Bacille Calmette-Guérin (BCG) revaccination didn't help prevent sustained Mycobacterium tuberculosis infection in initially uninfected adolescents without HIV in a randomized trial from South Africa.